Cell line · CVCL_0597
Ramos
Cancer cell line, Homo sapiens. Burkitt lymphoma. 82 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Ramos. Cell lines, record CVCL_0597. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0597
On this page
Cell line
As Cellosaurus gives it.
- Name
- Ramos
- Accession
- CVCL_0597
- RRID
- RRID:CVCL_0597
- Synonyms
- RAMOS, Ramos 1, RA 1, RA.1, Ra #1, Ra No. 1, Ramos(RA1), Ramos-RA1, Ramos (RA 1), Ramos (RA #1), Ramos (RA)
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 3Y
- Category
- Cancer cell line
- Diseases
- Burkitt lymphoma (NCIt C2912); Burkitt lymphoma (ORDO Orphanet_543)
- Derived from
- Ascites (in situ)
- Cell type
- B-cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers82
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| SorLA regulates B cell receptor uptake, trafficking, and B cell-mediated immune responses in vivo. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A 3D genome atlas of human tonsil and the role of loop extrusion in B cell somatic hypermutation. | Science | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies. | J Hematol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B-BCL6 Regulatory Circuit in Burkitt Lymphoma. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML. | Blood Neoplasia | 2025 | Its Methods give the RRID and name the line | PubMed | |
| DUSP11 is an Intracellular Innate Immune Checkpoint in Lung Adenocarcinoma. | Cancer Immunol Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. | Cancers (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 82
See all 82 papersRelatives23
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CellSensor ISRE-bla RA-1 | CVCL_KS64 | Cell lines | |
| Derived from it | CellSensor NFAT-bla RA-1 | CVCL_KS46 | Cell lines | |
| Derived from it | CellSensor NFkB-bla RA-1 | CVCL_KB47 | Cell lines | |
| Derived from it | CellSensor STAT6-bla RA-1 | CVCL_KS55 | Cell lines | |
| Derived from it | EDITGENE Ramos-CopGFP | CVCL_F6FT | Cell lines | |
| Derived from it | EDITGENE Ramos-FLUC | CVCL_F6G5 | Cell lines | |
| Derived from it | HyCyte Ramos KO-hCD22 | CVCL_F1SV | Cell lines | |
| Derived from it | HyCyte Ramos KO-hIRF1 | CVCL_E1MG | Cell lines | |
| Derived from it | HyCyte Ramos KO-hSEPTIN6 | CVCL_F1SW | Cell lines | |
| Derived from it | HyCyte Ramos KO-hSH3KBP1 | CVCL_E1MH | Cell lines |
1 to 10 of 23
See all 23 relativesCell banks11
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0597
GET https://conductscience.org/api/cell-lines/v1/CVCL_0597/papers?page=2